II. Physiology
- Maturation
- Forms in Bone Marrow from Myeloblasts as with other Granulocytes (Basophils, Neutrophils, Monocytes)
- Matures in Bone Marrow over 8 days
- Moves to peripheral blood where it spends 8-12 hours
- Moves to target tissue where it spends 1-2 weeks
- Function: Response to Allergy and Parasitic Infection
- Responds to Mast Cell, Basophil chemotactic factors
- Type 1 Hypersensitivity Response - Late Phase (hours after exposure)
- Phagocyte (engulfs extracellular pathogens)
- Parasite (e.g. Helminth) response
- Antigen Presenting Cell
- Eosinophil granule contents (Proteins)
- Antiparasitic Agents with tissue toxicity effect
- Neurotoxins
- Eosinophil-Derived Neurotoxin (EDN)
- Eosinophil Peroxidase (EPO) - also listed above
- Markers of Eosinophil activity in Asthma
- Other Proteins
- Charcot-Leyden Crystals
- Lysophosphatase
- Cytokines
-
Surface Receptors
- IgE Receptors
- IgE-Antigen complex binding results in Eosinophil activation and degranulation
- IgG Receptors
- Complement Receptors
- IgE Receptors
III. Labs: Morphology on Blood Smear
- Granulocyte stains brightly with Eosin Stain (due to Major Basic Protein or MBP)
- Bilobed nucleus
- Diameter: 12-17 microns
IV. Interpretation: Normal
- Range: 1-4% of peripheral blood cells
V. Types: Eosinophilia
- Familial Eosinophilia (Familial Hypereosinophilic Syndrome)
- Rare autosomal condition (most Hypereosinophilic Syndromes are not inherited)
- Acquired
- Primary Eosinophilia
- Idiopathic
- Hypereosinophilic Syndrome (>1500 Eosinophils/uL x6 months without known cause)
- Clonal Eosinophilia
- Acute Myeloid Leukemia and other malignancies (see below)
- Idiopathic
- Secondary Eosinophilia
- See below
- Primary Eosinophilia
VI. Causes: Increased (Eosinophilia)
- See Hypereosinophilic Syndrome
- Allergy
- Dermatologic Disorders
- Parasitic or Tropical infection (esp. worm infestation)
- Trichinosis
- Aspergillosis
- Hydatidosis
- Angiostrongylus
- Ascaris lumbricoides
- Capillariasis
- Cysticercosis
- Echinococcus
- Fascioliasis
- Filariasis
- Gnathostomiasis
- Paragonimiasis
- Schistosomiasis
- Strongyloidiasis
- Toxocara
- Trichuris trichiura
- Bacterial Infection
- Viral Infection
- Fungal Infection
- Myeloproliferative disorders and other Malignancies (primary clonal Eosinophilia)
-
Collagen-vascular diseases
- Rheumatoid Arthritis
- Periarteritis
- Systemic Lupus Erythematosus
- Eosinophilia-Myalgia Syndrome
- Linked to L-Tryptophan and 5-Hydroxytryptophan (5-HTP) usage in 1989 (suspected contaminant)
- Medications
- Antibiotics
- NSAIDS and antiinflammatory agents
- Psychiatric Agents
- Miscellaneous
- Chlorpropamide (hypoglycemic agent)
- Procarbazine (Chemotherapy)
- Miscellaneous
- Radiation Therapy
- Eosinophilic Gastroenteritis
- Sarcoidosis
- Addison's Disease
- Loffler's Syndrome
VII. Evaluation: Eosinophilia (Eosinophils >500/mm3)
- See Leukocytosis
- History and potential causes
- Travel history
- New medications
- Diagnostics (consider)
- Dermatitis biopsy (if present)
- Consider allergy and immunology Consultation or testing
- Consider Parasite testing (e.g. stool Ova and Parasites)
VIII. References
- Mahmoudi (2014) Immunology Made Ridiculously Simple, MedMaster, Miami, FL
- Saiki in Friedman (1991) Medical Diagnosis, p. 227
- Abramson (2000) Am Fam Physician 62(9):2053-60 [PubMed]
- Riley (2015) Am Fam Physician 92(11):1004-11 [PubMed]